Ellington Management Group’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-3,300
| Closed | -$313K | – | 415 |
|
|
2020
Q1 | $313K | Sell |
3,300
-3,100
| -48% | -$294K | 0.07% | 307 |
|
|
2019
Q4 | $564K | Buy |
+6,400
| New | +$564K | 0.12% | 126 |
|
|
2019
Q2 | – | Sell |
-3,100
| Closed | -$364K | – | 775 |
|
|
2019
Q1 | $364K | Sell |
3,100
-900
| -23% | -$106K | 0.07% | 285 |
|
|
2018
Q4 | $436K | Buy |
4,000
+1,200
| +43% | +$131K | 0.13% | 159 |
|
|
2018
Q3 | $358K | Buy |
+2,800
| New | +$358K | 0.1% | 281 |
|
|
2018
Q1 | – | Sell |
-6,800
| Closed | -$1.01M | – | 1029 |
|
|
2017
Q4 | $1.01M | Buy |
+6,800
| New | +$1.01M | 0.16% | 84 |
|
|
2017
Q1 | – | Sell |
-5,700
| Closed | -$818K | – | 872 |
|
|
2016
Q4 | $818K | Sell |
5,700
-1,700
| -23% | -$244K | 0.12% | 97 |
|
|
2016
Q3 | $874K | Buy |
+7,400
| New | +$874K | 0.24% | 92 |
|
|
2016
Q1 | – | Sell |
-3,000
| Closed | -$470K | – | 712 |
|
|
2015
Q4 | $470K | Buy |
+3,000
| New | +$470K | 0.17% | 142 |
|
|
2015
Q3 | – | Sell |
-1,200
| Closed | -$209K | – | 910 |
|
|
2015
Q2 | $209K | Sell |
1,200
-2,100
| -64% | -$366K | 0.05% | 582 |
|
|
2015
Q1 | $569K | Buy |
+3,300
| New | +$569K | 0.12% | 246 |
|
|
2014
Q3 | – | Sell |
-5,600
| Closed | -$496K | – | 472 |
|
|
2014
Q2 | $496K | Buy |
+5,600
| New | +$496K | 0.23% | 118 |
|